Frontiers
US$ 21.55
bpc 157 randomized trial The Stable Gastric Pentadecapeptide Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC-157 vs TB-500 After Surgery
Description
PMCID: PMC10401663
(Treatment Improvement Protocol (TIP) Series, No
Excipients: Povidone K-30, Lactose, Corn starch, Microcrystalline Cellulose, Colloidal silica dioxide, Talc, Magnesium stearate, Hydroxyproylmethylcellulose, , Red aluminium lake 4R, Polyethyleneglycol 6000, Propyleneglycol, Sodium saccharine
It targets telomere support and pineal gland regulation at the cellular level
